Clinical Efficacy of Sublingual Immunotherapy Is Associated With Restoration of Steady-State Serum Lipocalin 2 After SLIT: A Pilot Study

World Allergy Organization Journal - United Kingdom
doi 10.1186/s40413-018-0201-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Clinical Improvement After Escalation for Sublingual Immunotherapy (SLIT)

Ear, Nose and Throat Journal
MedicineOtorhinolaryngology
2011English

Immunological Effects of Sublingual Immunotherapy: Clinical Efficacy Is Associated With Modulation of Programmed Cell Death Ligand 1, IL-10, and IgG4

Journal of Immunology
AllergyImmunology
2010English

Evaluation of Peanut Sublingual Immunotherapy for Peanut Allergy: A Pilot Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Rush Sublingual Immunotherapy in Canine Atopic Dermatitis: A Prospective Pilot Study

Polish Journal of Veterinary Sciences
2016English

Biomarkers of 12 SQ House Dust Mite Sublingual Immunotherapy (SLIT)-Tablet Treatment After Nasal Allergen Challenge

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Prs40 - Cost-Effectiveness of the Sq® Grass Sublingual Immunotherapy (Slit) Tablet in a Paediatric Population

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Dose Dependence of Efficacy but Not of Safety in Sublingual Immunotherapy

Monaldi Archives for Chest Disease
Cardiovascular MedicinePulmonaryRespiratory MedicineCardiology
2016English

Resting-State Functional Connectivity After Concussion Is Associated With Clinical Recovery

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2018English

The Evidence Based Efficacy of Sublingual Immunotherapy for Allergic Rhinitis, Which Is the Most Appropriate Estimate?

Journal of Allergy & Therapy
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy